Jan 24, ‘23
QuartzBio, a Part of Precision for Medicine, Acquires SolveBio and Expands Software-as-a-Service (SaaS) Data Management Solutions for Clinical Research & Development (R&D)
Discover
Nov 10, ‘22
Precision for Medicine, GmbH CIR (French Research Tax Credit) Accreditation Updates
Discover
Nov 03, ‘22
Precision for Medicine Accelerating Precision Oncology with Next Generation Screening to Support New Cancer Diagnostics
Discover
Jun 06, ‘22
Advaxis Presents Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in Metastatic Non-Small-Cell Lung Cancer (NSCLC)
Discover
May 03, ‘22
Precision for Medicine Receives Top Recognition in CRO Leadership Awards
Discover
Dec 07, ‘21
Deep Lens Announces Launch of Real Time Feasibility Offering to Assist in Oncology Clinical Trial Design and Site Selection
Discover
